{
    "id": 21714,
    "cites": 41,
    "cited_by": 6,
    "reference": [
        "Alpert, A. 2015. The anticipatory effects of Medicare Part D on drug utilization. Mimeo. Andrade, S., et al. 2006. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety. 15(8):565-574.",
        "Avery, R., Eisenberg, M. and K. Simon. 2012. The impact of direct-to-consumer television and magazine advertising on antidepressant use. Journal of Health Economics. 31:705-718.",
        "Blume-Kohout, M. and N. Sood. 2013. Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development. Journal of Public Economics. 97:327-336.",
        "Bradford, W., et al. 2006. How direct-to-consumer television advertising for osteoarthritis drugs affect physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 prescribing behavior. Health Affairs. 25(5):1371-1377.",
        "Centers for Medicare and Medicaid Services. 2012. Chronic conditions among Medicare beneficiaries.",
        "Dave, D. 2013. Effects of pharmaceutical promotion: A review and assessment. NBER Working Paper 18830.",
        "Dave, D. and H. Saffer. 2012. Impact of direct-to-consumer advertising on pharmaceutical prices and demand. Southern Economic Journal. 79(1): 97-126.",
        "DiMatteo, M., et al. 2002. Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care. 40(9): 794-811.",
        "Donohue, J., Berndt, E., Rosenthal, M., et al., 2004. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care. 42(12): 1176\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1185.",
        "Duggan, M. and Scott Morton, F. 2010. The impact of Medicare Part D on pharmaceutical prices and utilization. American Economic Review. 100(1):590-607.",
        "Goldman, D., Joyce, G., and Zheng, Y. 2007. Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. Journal of the American Medical Association. 298(1):61-69.",
        "Goldman, D., et al. 2004. Pharmacy benefits and the use of drugs by the chronically ill. Journal of the American Medical Association. 291(19): 2344-2350.",
        "Hess, L, et al. 2006. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Annals of Pharmacotherapy. 40:1280-1288.",
        "Hirschfeld, R, et al. 1997. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. Journal of the American Medical Association. 277(4):333-340.",
        "Hollon, M. 2005. Direct-to-consumer advertising: A haphazard approach to health promotion.",
        "Holmer, A. 2002. Direct-to-consumer advertising\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dstrengthening our health care system. New England Journal of Medicine. 346(7):526-528.",
        "Iizuka, T. and G. Jin. 2005. The effect of prescription drug advertising on doctor visits. Journal of Economics and Management Strategy. 14(3): 701\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c727.",
        "Imbens, G. and J. Angrist. 1994. Identification and Estimation of Local Average Treatment Effects. Econometrica. 62(2):467-475.",
        "Joyce, G., Goldman, D., Karaca-Mandic, P., and Y. Zheng. 2007. Pharmacy benefit caps and the chronically ill. Health Affairs. 26(5): 1333-1344.",
        "Kalyanaram, G., 2009. The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs. International Journal of Pharmaceutical and Healthcare Marketing. 3(2):137-148.",
        "Kanazawa, M. and J. Funk. 2001. Racial discrimination in professional basketball: Evidence from Nielsen ratings. Economic Inquiry. 39(4): 599\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c608.",
        "Kantar Media. 2011. Pharmaceutical Marketing. Ad Age Insights White Paper, October 17, 2011.",
        "Kearney, M. and P. Levine. 2014. Media influences on social outcomes: The impact of MTV\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s 16 and Pregnant on teen childbearing. NBER Working Paper 19795.",
        "Ketcham, J. and K. Simon. 2008. Medicare Part D's effects on elderly drug costs and utilization. American Journal of Managed Care. 11:SP14-22.",
        "Kravitz, R., et al. 2005. Influence of patients\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 requests for direct-to-consumer advertised antidepressants: A randomized controlled trial,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of the American Medical Association. 293(16):1995-2002.",
        "Lakdawalla, D., Sood, N., and Q. Gu. 2013. Pharmaceutical advertising and Medicare Part D.",
        "Lakdawalla, D., and W. Yin. 2015. Insurers' negotiating leverage and the external effects of Medicare Part D. Review of Economics and Statistics. 97(2):314-331.",
        "Lichtenberg, F. and Sun, S. 2007. The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs. 26(6):1735-1744.",
        "Majumdar, S., Gurwitz, J., and S. Soumerai. 1999. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. Journal of General Internal Medicine. 14(12):711-717.",
        "Nielsen. 2014. The total audience report. December Issue.",
        "Peterson, A., et al. 2007. A checklist for medication compliance and persistence studies using retrospective databases. Value in Health. 10:3\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c12.",
        "Rosenthal, M., et al. 2003. Demand effects of recent changes in prescription drug promotions. Frontiers in health policy research. 6:1-26.",
        "Saffer, H., Wakefield, M. and Y. Terry-McElrath. 2007. The effect of nicotine replacement therapy advertising on youth smoking. NBER Working Paper 12964.",
        "Sethuraman, R., Tellis, G., and R. Briesch. 2011. How well does advertising work? Generalizations from meta-Analysis of brand advertising elasticities. Journal of Marketing Research. 48(3):457-471.",
        "Shapiro, B. 2015. Positive spillovers and free riding in advertising of prescription pharmaceuticals: The case of antidepressants. Mimeo.",
        "Sinkinson, M. and A. Starc. 2015. Ask your doctor? Direct-to-consumer advertising of pharmaceuticals. NBER Working Paper 21045.",
        "Stock, J., Wright, J., and M. Yogo. 2002. A survey of weak instruments and weak identification in GMM. Journal of Business and Economic Statistics. 20(4):518\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c529.",
        "Viswanathan M, et al. 2012. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: A systematic review. Annals of Internal Medicine. 157:785-795.",
        "Wosinska, M. 2002. Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products. Harvard Business School Marketing Research Papers No. 02-04.",
        "Wosinska, M. 2005. Direct-to-consumer advertising and drug therapy compliance. Journal of Marketing Research. 42(3): 323-332.",
        "Yin, W. et al. 2008. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Annals of Internal Medicine. 148(3):169-177."
    ]
}